The spread of the coronavirus was deemed a global pandemic by the World Health Organization (WHO). Coronavirus' quick spread prompted a global lockdown in 2020. The Covid-19 pandemic had a mediocrely positive effect on the world market for peptide therapeutics. Early on in the pandemic, key players in the Peptide Based Infection Therapeutics Market suffered significant financial losses due to adverse effects from delayed clinical trials, delayed peptide drug approvals, and a lack of workforce.
Cancer and other metabolic disorders may be treated with peptide medications. Due to the restrictions put in place during the pandemic, these medications were in short supply.
Read More:
https://cmitoc.blogspot.com/2023/02/global-peptide-based-infection.html
